Expansion into publicly available bulk and single cell uveal melanoma sequencing data allowed to evaluate our findings in independent cohorts of primary and metastatic tumours and to study the role of wild-type CYSLTR2 in melanomas with a mutation in GNAQ, GNA11 or PLCB4 [13, 14]. This evidence concerns the gene PLCB4 and uveal melanoma.